Skip to main content

Table 3 Statistical comparison between HCC patients and liver cirrhosis patients regarding p16 methylation status

From: Aberrant p16 methylation as an early diagnostic marker in blood of hepatocellular carcinoma patients

P16 methylation status

HCC, n = 30

Liver cirrhosis, n = 15

Fisher

p value

Methylated (%)

26/30 (86.7%)

0/15

36.111

< 0.01*

Unmethylated (%)

4/30 (13.3%)

15/15 (100%)

  1. *p < 0.01, highly significant difference